306 related articles for article (PubMed ID: 29724812)
21. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
22. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
Agajanian M; Runa F; Kelber JA
Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
[TBL] [Abstract][Full Text] [Related]
23. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
24. The Nuclear Receptor, RORγ, Regulates Pathways Necessary for Breast Cancer Metastasis.
Oh TG; Wang SM; Acharya BR; Goode JM; Graham JD; Clarke CL; Yap AS; Muscat GEO
EBioMedicine; 2016 Apr; 6():59-72. PubMed ID: 27211549
[TBL] [Abstract][Full Text] [Related]
25. RSK3 switches cell fate: from stress-induced senescence to malignant progression.
Huna A; Flaman JM; Lodillinsky C; Zhu K; Makulyte G; Pakulska V; Coute Y; Ruisseaux C; Saintigny P; Hernandez-Vargas H; Defossez PA; Boissan M; Martin N; Bernard D
J Exp Clin Cancer Res; 2023 Nov; 42(1):318. PubMed ID: 38008756
[TBL] [Abstract][Full Text] [Related]
26. HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer.
Gupta P; Srivastava SK
Mol Oncol; 2014 Dec; 8(8):1532-47. PubMed ID: 24994678
[TBL] [Abstract][Full Text] [Related]
27. Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.
Jin M; Gao D; Wang R; Sik A; Liu K
Oncol Rep; 2020 Aug; 44(2):555-564. PubMed ID: 32627030
[TBL] [Abstract][Full Text] [Related]
28. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
29. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
30. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.
Tian H; Liu J; Chen J; Gatza ML; Blobe GC
Oncogene; 2015 Nov; 34(45):5635-47. PubMed ID: 25823021
[TBL] [Abstract][Full Text] [Related]
31. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b.
Zhou W; Ye XL; Xu J; Cao MG; Fang ZY; Li LY; Guan GH; Liu Q; Qian YH; Xie D
Sci Signal; 2017 Jun; 10(483):. PubMed ID: 28611183
[TBL] [Abstract][Full Text] [Related]
32. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
33. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
34. FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT.
Hopkins A; Coatham ML; Berry FB
Mol Cancer Res; 2017 Oct; 15(10):1341-1353. PubMed ID: 28684636
[TBL] [Abstract][Full Text] [Related]
35. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
36. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
37. ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling.
Lei T; Lin Y; Lai X; Zhang Y; Ma Y; Wang X; Liu W; Tang Q; Yang T; Feng W; Song W
Cancer Lett; 2024 Jun; 592():216953. PubMed ID: 38729557
[TBL] [Abstract][Full Text] [Related]
38. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
Serrano I; McDonald PC; Lock FE; Dedhar S
Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
[TBL] [Abstract][Full Text] [Related]
39. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
40. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
